Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 245.70
-10.20 (-3.99%)
At close: Jul 7, 2026
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 3.12 billion as of July 8, 2026. Its market cap has decreased by -39.93% in one year.
Market Cap
3.12B
Enterprise Value
3.29B
Revenue
2.01B
Ranking
n/a
PE Ratio
34.56
Stock Price
245.70
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.12B, an increase of 2,779.54%. That is a compound annual growth rate of 16.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 3.12B | -32.32% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Albert David | 4.02B |
| Medico Remedies | 3.35B |
| Trident Lifeline | 3.15B |
| BDH Industries | 2.96B |
| Everest Organics | 2.76B |
| Astonea Labs | 2.75B |
| Gennex Laboratories | 2.49B |
| Ambalal Sarabhai Enterprises | 2.47B |